Dxcover Expands Leadership Team with Clinical and Commercial Experts
Cancer diagnostics company adds three clinical advisors and two board members to support commercial growth and platform expansion.
Cancer diagnostics company adds three clinical advisors and two board members to support commercial growth and platform expansion.
The Alzheimer's Association released its first clinical practice guideline on the use of blood-based biomarker tests.
The platform aims to offer more consistent and precise characterization at diagnosis and tracking of fibrosis in patients with metabolic dysfunction-associated steatohepatitis.
California-based company adds quality management certification to existing FDA registration and pharmacy licensing for lab testing kit fulfillment operations.
Multi-disciplinary cancer center will implement Halo Intelligence platform to enhance precision oncology capabilities across Pacific Northwest.